• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Lipid Regulators (Statin Types Only) and Their Significance Are Monitored For Period of 2000 Through To 2010 on a Global Scale

Posted on: Thursday, 19 October 2006, 12:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c43816) has announced the addition of Lipid Regulators - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Lipid Regulators (Statin types only) in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 31 companies including many key and niche players worldwide. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Content Outline:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Global Market Overview and Analysis

2. Industry Overview

3. Trends and Issues

4. Product Overview

5. Branded Statins

6. Statins & Its Significance

7. Types of Non-Statins

8. Regulatory Environment

9. Recent Industry

10. Focus on Select Players

11. Global Market Perspective

III. MARKET

1. The United States

2. Canada

3. Japan

4. Europe

5. Rest of World

IV. COMPETITION

The Companies mentioned inside this report include:

Abbott Laboratories (USA)

Andrx Corporation (USA)

Astellas Pharma, Inc (Japan)

AstraZeneca PLC (UK)

Astrazeneca Pharmaceuticals LP (USA)

Bentley Pharmaceuticals, Inc (USA)

Biocon India Limited (India)

Bristol-Myers Squibb Company (USA)

Daiichi Sankyo Co, Ltd (Japan)

Daiichi Sankyo Pharma, Inc (USA)

Ethypharm SA (France)

Fournier Pharma, Inc (Canada)

GlaxoSmithKline PLC (UK)

Impax Laboratories, Inc (USA)

Johnson & Johnson (USA)

Kos Pharmaceuticals, Inc (USA)

Krka, Tovarna Zdravil, dd, Novo Mesto (Slovenia)

Merck & Co, Inc (USA)

Merck Frost Canada Ltd (Canada)

Merck Frosst/Schering Pharmaceuticals (Canada)

Merck/Schering-Plough Pharmaceuticals (USA)

Metkinen Oyj (Finland)

Novartis AG (Switzerland)

Novartis Pharmaceuticals Corporation (USA)

Novartis Pharmaceuticals Canada, Inc (Canada)

Pfizer, Inc (USA)

Pfizer Canada, Inc (Canada)

Pfizer GmbH (Germany)

Pfizer Ireland Pharmaceuticals (Ireland)

Pfizer Japan, Inc (Japan)

Pharmac (New Zealand)

QUATRx Pharmaceuticals Co (USA)

Ranbaxy Laboratories Ltd (India)

Reliant Pharmaceuticals, Inc (USA)

Schering-Plough Corporation (USA)

Sopharma Jsc (Bulgaria)

Strides Arcolabs Limited (India)

Teva Pharmaceutical Industries Ltd (Israel)

Zentiva AS Praha (Czech Republic)

Zydus Cadila (India)

For more information visit http://www.researchandmarkets.com/reports/c43816

Source: Business Wire

More News in this Category